Skip to main content

GoodRx unveils new e-commerce platform, launches with Opill

The first over-the-counter daily birth control pill is available to order via GoodRx’s new direct-to-consumer shopping experience.
Levy
goodrx x opill

GoodRx announced the rollout of a new e-commerce solution, with Opill as its launch partner. 

This new seamless direct-to-consumer shopping experience allows consumers to order eligible health products and medications on the GoodRx platform and have them shipped directly to their door. Not only does this mark GoodRx’s entry into the over-the-counter market, but it offers valuable partnership opportunities for consumer health and pharmaceutical brands looking to leverage GoodRx’s extensive reach and scale.

The introduction of this new e-commerce service is part of GoodRx’s broader strategy to further integrate health and wellness brands into its platform, streamlining the purchasing process and increasing accessibility of essential products and medications. Now, consumers have another way of conveniently ordering Opill contraception directly to their doorsteps without the need for a doctor visit or prescription. This new GoodRx capability allows consumer health and pharmaceutical brands looking to provide a frictionless experience for consumers to integrate their offerings directly within the GoodRx platform.

"We are thrilled to launch our e-commerce solution with Opill, an initiative that underscores our mutual commitment to more accessible health care," said Dorothy Gemmell, chief commercial officer at GoodRx. "This new feature will provide patients with a simple, seamless way to obtain their eligible medications, building on how GoodRx has already made prescription medications more affordable and accessible for millions of consumers. It also paves the way for other OTC brands and pharma partners to leverage our platform’s reach to expand market presence, increase consumer access to essential medications and ultimately help drive growth."

[Read more: GoodRx unveils Medicine Cabinet]

The GoodRx and Opill partnership addresses significant gaps in healthcare access, particularly for the more than 19 million women living in areas with limited contraceptive services. By removing major obstacles, such as high costs and logistical challenges, this initiative provides another avenue for direct access to OTC birth control. 

“Perrigo worked for years to bring a U.S. daily oral birth control option over the counter, providing a solution to those experiencing barriers like a lapse in insurance coverage and a historic lack of effective options available without a prescription,” said Sara Young, senior vice president and chief growth and transformation officer at Perrigo, the manufacturer of Opill. “Teaming up with GoodRx allows us to leverage its broad user base and easy-to-use platform to make it simple for women to directly order Opill, which is currently the most effective birth control option available without a prescription.”

Leveraging deep insights into consumer health behavior, GoodRx’s new e-commerce experience aligns with the surge in consumer demand for more autonomy over healthcare management, a trend accelerated by the global COVID-19 pandemic.

[Read more: GoodRx debuts Prescription Cost Tracker]

X
This ad will auto-close in 10 seconds